For this item I can put my feet up and let our esteemed colleague Merrill Goozner do all the heaving lifting over at http://www.gooznews.com/node/2941.
GoozNews offers a comprehensive summary of a new policy thrust at the FDA, under the new leadership team, that promises stricter policing of direct-to-consumer advertising, both television and online. We can expect much better efforts to assure that the negative aspects of drugs are highlighted alongside the positives. (No more reading a list of 900 side effects during the last 1.2 seconds of the ad.) And the industry appears to be paying attention.